These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3954782)

  • 21. [Potentiation of the antitumor activity of 5-fluorouracil by biochemical modulators].
    Inaba M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):380-91. PubMed ID: 3279910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental study of the combined effect of 5-fluorouracil and cyclophosphane on growth of Zajdela hepatoma and nucleic acid metabolism].
    Reztsova VV; Stukov AN; Filov VA
    Biull Eksp Biol Med; 1980 Oct; 90(10):469-71. PubMed ID: 7426710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced response of leukemia (L1210) mice to combination chemotherapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) and 5-fluorouracil (NSC-19893).
    Kline I; Woodman RJ; Gang M; Waravdekar VS; Goldin A; Venditti JM
    Cancer; 1971 Jun; 27(6):1363-8. PubMed ID: 5088212
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhanced antitumor effect of 5'-deoxy-5-fluorouridine by oral administration with L-cysteine.
    Iigo M; Nakajima Y; Araki E; Hoshi A
    Jpn J Cancer Res; 1989 Feb; 80(2):182-7. PubMed ID: 2524459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance.
    Wang FS; Aschele C; Sobrero A; Chang YM; Bertino JR
    Cancer Res; 1993 Aug; 53(16):3677-80. PubMed ID: 8339275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of the antitumor action of 5-fluorouracil].
    Reztsova VV; Filov VA; Stukov AN
    Dokl Akad Nauk SSSR; 1980; 253(2):488-91. PubMed ID: 7428592
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of the growth of sarcoma 180 ascites cells by combinations of inhibitors of nucleic acid biosynthesis and the cupric chelate of kethoxal bis-(thiosemicarbazone).
    Sartorelli AC; Booth BA
    Cancer Res; 1967 Sep; 27(9):1614-9. PubMed ID: 6051275
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
    Houghton JA; Cheshire PJ; Hallman JD; Lutz L; Luo X; Li Y; Houghton PJ
    Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of erbstatin, a tyrosine protein kinase inhibitor.
    Imoto M; Umezawa K; Komuro K; Sawa T; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1987 Apr; 78(4):329-32. PubMed ID: 3108212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular basis of the relation between the cytotoxic effect of antineoplastic compounds and the cell cycle phase].
    Belousova AK
    Vopr Onkol; 1972; 18(8):88-96. PubMed ID: 4348595
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of schedule on leucovorin potentiation of fluorouracil antitumor activity in dietary folic acid deplete mice.
    Raghunathan K; Schmitz JC; Priest DG
    Biochem Pharmacol; 1997 Apr; 53(8):1197-202. PubMed ID: 9175725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
    Ismail A; Van Groeningen CJ; Hardcastle A; Ren Q; Aherne GW; Geoffroy F; Allegra CJ; Grem JL
    Mol Pharmacol; 1998 Feb; 53(2):252-61. PubMed ID: 9463483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
    Laudonio N; Zupi G; Erba E; Leonetti C; D'Incalci M
    Br J Cancer; 1990 Mar; 61(3):377-81. PubMed ID: 2328201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative in vitro studies with 5-fluorouracil and some of its derivatives].
    Weitzel G; Warnecke P; Seeber S
    Hoppe Seylers Z Physiol Chem; 1969 Jun; 350(6):734-40. PubMed ID: 4240568
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of N1-(2'-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on nucleic acid and protein biosyntheses in Ehrlich ascites cells.
    Fujimoto S; Akao T; Itoh B; Koshizuka I; Koyano K
    Cancer Res; 1976 Jan; 36(1):33-6. PubMed ID: 1248008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporation of 5-fluorouracil into RNA of normal tissues and an adenocarcinoma in protein-deprived rats.
    el Hag IA; Jakobsson B; Erichsen C; Christensson PI; Jönsson PE; Stenram U
    In Vivo; 1987; 1(4):215-20. PubMed ID: 2485132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.
    Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J
    Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism.
    Cadman E; Heimer R; Davis L
    Science; 1979 Sep; 205(4411):1135-7. PubMed ID: 472732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.